Evidence map›Paper›PMID 36771474›Full record

ReviewNutrients2023

Effects of Vitamin D on Cardiovascular Risk and Oxidative Stress.

Guilherme Renke, Bernardo Starling-Soares, Thomaz Baesso, Rayssa Petronio, Danilo Aguiar, Raphaela Paes

Abstract readReview
In one paragraph

Review in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Guilherme RenkeNational Institute of Cardiology, Brazilian Ministry of Health, Rio de Janeiro 21040-900, Brazil.ORCID 0000-0002-7940-3667
Bernardo Starling-SoaresExtreme Sports Nutrition Institute-INEE, Belo Horizonte 31270-901, Brazil.ORCID 0000-0002-0730-7684
Thomaz BaessoNutrindo Ideais Performance and Nutrition Research Center, Rio de Janeiro 22640-100, Brazil.
Rayssa PetronioNutrindo Ideais Performance and Nutrition Research Center, Rio de Janeiro 22640-100, Brazil.
Danilo AguiarNutrindo Ideais Performance and Nutrition Research Center, Rio de Janeiro 22640-100, Brazil.
Raphaela PaesNutrindo Ideais Performance and Nutrition Research Center, Rio de Janeiro 22640-100, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionVitamin D has been primarily studied as an important factor influencing bone and calcium metabolism. Metabolites of vitamin D are essential for whole-body calcium homeostasis, maintaining serum calcium levels within a narrow range by regulating this process in the bones and gut. Nevertheless, its deficiency is also related to increased risk of type 2 diabetes mellitus (T2DM), metabolic syndrome (MS), and cardiovascular disease (CVD)-with increased visceral adipose tissue and body mass index (BMI), as well as the frequently associated hypercholesterolemia. It has been reported that vitamin D levels are inversely related to cardiovascular (CV) risk in men and women. However, the effects of vitamin D on distinct outcomes in women and the dose of supplementation needed to improve clinical endpoints have not been established. 25-Hydroxyvitamin D [25(OH)D] reduces systemic inflammatory mediators in CVD and favors the release of anti-inflammatory cytokines from the immune system. In addition, 25(OH)D can be primarily converted into calcitriol (1,25-dihydroxycholecalciferol [1,25(OH)2D]) in the kidneys through the action of the 1-α-hydroxylase enzyme. Calcitriol, through the downregulation mechanism of renin expression, renin-angiotensin-aldosterone system (RAAS) activity, and its interaction with the vitamin D receptor, can bring CV benefits. The calcitriol form also lowers parathyroid hormone (PTH) levels by indirectly causing a reduction in aldosterone and mineralocorticoid synthesis. Elevated plasma aldosterone is related to endothelial dysfunction and CVD in hypovitaminosis D status.

conclusionVitamin D supplementation may benefit certain risk groups, as it improves metabolic variables, reducing oxidative stress and CV outcomes. More studies are needed to define interventions with vitamin D in men and women.

Indexed as

Cardiovascular DiseasesDiabetes Mellitus, Type 2Vitamin D DeficiencyAldosteroneCalcitriolCalciumFemaleHeart Disease Risk FactorsHumansMaleOxidative StressParathyroid HormoneRisk FactorsVitamin DVitaminsAldosteroneCalcitriolCalciumParathyroid HormoneVitamin DVitamins25-hydroxyvitamin D [25(OH)D], 1,25-dihydroxycholecalciferol [1,25(OH)2D], calcitriolcardiovascularoxidative stressvitamin D

Identifiers

PMID36771474
PMCPMC9920542

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.